Wave Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,395	1,887	602	608	185	384
Market Cap Growth	35.74%	213.59%	-1.10%	229.32%	-51.88%	39.68%
Enterprise Value	2,203	1,611	503	533	95	206
Last Close Price	12.59	12.37	5.05	7.00	3.14	7.87
PS Ratio	21.78	17.42	5.31	166.72	4.51	19.12
PB Ratio	16.20	8.68	12.67	-16.35	4.58	4.24
P/TBV Ratio	19.10	9.01	15.18	-	5.68	4.64
EV/Sales Ratio	20.16	14.87	4.44	146.02	2.33	10.24
Debt / Equity Ratio	0.15	0.12	0.68	-1.01	0.74	0.32
Net Debt / Equity Ratio	-1.33	-1.27	-3.54	1.37	-2.99	-1.71
Net Debt / EBITDA Ratio	1.33	2.60	2.67	0.33	1.01	1.07
Net Debt / FCF Ratio	0.89	1.82	8.19	0.39	1.35	1.32
Asset Turnover	0.36	0.35	0.54	0.02	0.17	0.07
Quick Ratio	2.40	2.74	1.19	1.24	2.35	1.77
Current Ratio	2.51	2.89	1.26	1.38	2.53	1.90
Return on Equity (ROE)	-86.51%	-73.24%	-1118.17%	-10258.19%	-186.60%	-184.78%
Return on Assets (ROA)	-28.33%	-22.00%	-20.17%	-57.56%	-32.65%	-34.02%
Return on Capital Employed (ROCE)	-87.40%	-45.80%	-76.80%	-217.40%	-88.90%	-97.00%
Earnings Yield	-5.13%	-5.14%	-9.56%	-26.60%	-66.17%	-39.05%
FCF Yield	-8.33%	-8.05%	-3.42%	-21.23%	-48.48%	-30.56%
Buyback Yield / Dilution	-30.63%	-30.33%	-34.55%	-52.16%	-32.12%	-15.83%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q